Home » Good News in english, News in English of the world

‘Female Viagra’ discovery claim. New Female Sex Drug Results To Be Released

Inserito da

Flibanserin Study Results Announced. The number of Satisfying Sexual Events recorded by women using the experimental female sexual dysfunction medication flibanserin was considerably greater than those using a placebo and the amount of distress linked to the suffering of Hypoactive Sexual Desire Disorder (HSDD) was significantly reduced too. This information comes from the phase three clinical trial undertaken by the manufacturer of flibanserin, namely Boehringer Ingelheim who have just released their much awaited findings at the 12th Congress of the European Society for Sexual Medicine happening in Lyon, France. Flibanserin Study Results Announced. The study which was done on premenopausal women over a six month period saw an increase in the number of SSE’s from 2.8 to 4.5 by the end of the study period compared to 2.7 to 3.7 for the placebo. Interestingly not only did the drug produce more frequent SSE’s but it also produced higher levels of sexual desire in the women participants when compared to those using the placebo. The 1,400 women who took part in the study generally tolerated the flibanserin well and adverse events were reported at fifteen percent compared to seven percent for the placebo. Adverse events included drowsiness, dizziness, general tiredness, anxiety, a dry mouth, nausea and insomnia. The results were recorded using an eDiary which reminded volunteers to record all details of their sexual desire and sexual activity as well as making use of the precise Female Sexual Function Index (FSFI). Professor Anita Clayton from the University of Virginia and who was co author of this study said that the results showed “exciting progress” in the research of female sexual dysfunction and its possible treatment using flibanserin. She described female sexual dysfunction as an “under recognised condition”. Peter Piliero from Boehringer Ingelheim said that sexual desire problems could affect all women and commented that this new data provided “valuable scientific knowledge about HSDD”.

The German pharmaceutical company Boehringer Ingelheim GmbH has been taking its time releasing results about its possible blockbuster female sexual dysfunction drug flibanserin but has promised to release clinical testing which shows that the drug is safe and effective next week at a conference of the European Society for Sexual Medicine.  Their clinical testing which has been done on over 5,000 American and European women could prove that a large part of female sexual dysfunction is actually in the brain! According to Professor Jim Pfaus, a neurologist working at Concordia University in Canada the flibanserin drug functions by preventing the release of an important mood compound called serotonin, which in turn triggers production of another important mood regulating compound called dopamine which is known to produce increased sexual desire in women. Professor Pfaus also said that flibanserin could be more effective than the presently available in the UK female sexual dysfunction drug Intrinsa. He said that while Intrinsa could help women to “climb over” the wall of female sexual dysfunction, flibanserin would actually remove the problem. In the same way that erectile dysfunction causes great distress to men, female sexual dysfunction is estimated to cause relationship tension in as many as ten percent of relationships. The condition which has been named hypoactive sexual desire disorder (HSDD) is fast becoming a much talked about medical condition in the same way that erectile dysfunction started to be talked about with the arrival of Viagra. Unlike Viagra which produces almost instant results, the flibanserin medication requires for women to take it every day and they should only expect results in between three and six weeks later. The clinical testing process made use of personal digital monitors which reminded volunteers daily to rate their sexual desire levels and to report whether they had had sex and to rate its enjoyment. Ukmedix News will be keeping you up to date on any new clinical results regarding flibanserin.

the sexual functioning of women is more complicated.  The important female hormone oestrogen has been shown to increase levels of male aggressiveness in lab mice according to recent research done at the University of California San Francisco. The researchers claim that their study shows that oestrogen plays a very important role in the territorial behaviour of male mice which previously was not apparent. Oestrogen Research Leads To New Findings.  Professor Nirao Shah from the University of California explained that oestrogen is not only connected with the sexual behaviour of females but also linked to the sexual and territorial habits of male mice too. Explaining further Professor Shah said that the way that science should view male and female sexual behaviour has been changed by these recent findings.The research also suggests that when testosterone in the brain is converted into oestrogen by an enzyme called aromatase that this is essential for activating the brain circuits which are responsible for controlling male territorial and sexual behaviour. This research should be of specific interest to scientists studying ways of improving female sexual function. The importance of both testosterone and oestrogen for women who seek to improve their sexual function is already known but the exact brain mechanisms and functions which are so important for good female sexual function are not fully understood yet. Unlike men who are able to get instant sexual response with the drugs Viagra, Cialis and Levitra the sexual functioning of women is more complicated and needs much more research before an instant “Female Viagra” becomes readily available.The medication Intrinsa which is the only Female Sexual Dysfunction prescription remedy available in the UK works by releasing very small amounts of testosterone into the bloodstream and has had good results with many women. Women going through menopause often suffer from low levels of testosterone which is normally associated with men but is necessary in smaller quantities in women not only for good sexual function but also for general well being.  news from ukmedix.com


Dear friend,
this is an open project and accepts the help of anyone willing to make positive thinking…
Send your proposals (articles, cartoons, funny pictures and videos) and find an open door where to move your ideas … POSITIVE!
Support and Spread the only e-magazine dedicated to good news and smiles!

Write to: goodnewsenglish@goodnews.ws
Show on your site a link to our www.goodnews.ws